Literature DB >> 2735279

High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?

A S Smith1, D M Meisler, M A Weinstein, R L Tomsak, M R Hanson, R A Rudick, B K Farris, R M Ransohoff.   

Abstract

The vast majority of periventricular abnormalities visualized with MR imaging in patients less than 50 years old represents multiple sclerosis (MS) lesions. There are many other causes of periventricular lesions, most of which can be differentiated from MS on the basis of history and physical or MR findings. Five cases of biopsy- or Kveim test-proved sarcoidosis with MR findings consistent with MS are reported. Each of these patients, diagnosed as having sarcoidosis, had symptoms identical to those seen in MS. Although these patients have not had histologic characterization of the intraparenchymal lesions seen on MR, they illustrate the difficulty of differentiating sarcoidosis with CNS involvement from MS in some patients on the basis of clinical, radiographic, electrodiagnostic, or CSF testing. This series contributes to a growing body of evidence that neurosarcoidosis probably should be included in the differential diagnosis of isolated periventricular lesions in patients less than 50 years old.

Entities:  

Mesh:

Year:  1989        PMID: 2735279     DOI: 10.2214/ajr.153.1.147

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  CT and MR imaging of CNS lymphomatoid granulomatosis.

Authors:  R Kerslake; D Rowe; B S Worthington
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Neurosarcoidosis without systemic sarcoidosis.

Authors:  N Sommer; M Weller; D Petersen; H Wiethölter; J Dichgans
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Neurosarcoidosis with unusual MRI findings.

Authors:  M S Handler; L M Johnson; A R Dick; S Batnitzky
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

Review 4.  Endocrine aspects of neurosarcoidosis.

Authors:  G Murialdo; G Tamagno
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

5.  Neurosarcoidosis.

Authors:  David Lacomis
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.